Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017
Added 2 months ago Drug news
Celgene and BeiGene Ltd collaborate to licence BGB A317 an advanced PD I inhibitor to Celgene and to licence certain Celgene products to BeiGene in China.
Celgene Corporation and BeiGene, Ltd. entered into a strategic collaboration to develop and commercialize BeiGene's investigational anti-programmed cell death protein...
Added 5 months ago Drug news
Merck Inc.and Incyte Corpn. announce extended development programme for combinations of Keytruda (pembrolizumab) and epacadostat.
Incyte Corporation and Merck announced additional details of their clinical development program investigating the combination of epacadostat, Incyte’s investigational oral...
Added 10 months ago Drug news
Trailblaze Pharos companion diagnostic receives EU CE mark approval for use with entrectinib in solid tumours- Ignyta
Ignyta has announced that it has received Expedited Access Pathway (EAP) designation from the United States FDA and also CE...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...
Added 4 years ago
The original guidelines described the management of oesophageal and gastric cancer within existing practice. This paper updates the guidance to...
Added 6 years ago
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Background: Following CT, guidelines for staging oesophageal and gastro-oesophageal junction (GOJ) cancer recommend endoscopic ultrasonography (EUS), PET-CT and laparoscopy for T3-T4 GOJ tumours. These...
Added 1 year ago
Cancer constitutes an enormous burden on society in more and less economically developed countries alike.
Added 2 years ago
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
BACKGROUND: Vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression...
Added 3 years ago
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.
Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice
- Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
- Credits available
- Registration required
- Subscription fee